In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Loreen Willenberg may be the first person to be cured of HIV without a bone marrow transplant, but there’s more to this elite controller.
A small subset of people living with HIV are able to control viral replication without antiretroviral treatment.
People living with chronic illnesses are coming up with ingenious coping mechanisms in the face of COVID-19.
March 2021 marks the 250th issue of POZ magazine. To commemorate this milestone, we’ve created this special poster showcasing our covers.
In this special issue focused on women, we spotlight the stories of fierce women, including Loreen Willenberg, our cover subject.
Restorative justice can uplift Black transgender and queer people and people living with HIV.
Jordan Eagles creates art with human blood and superheroes.
An HIV prevention roundup
These dates represent milestones in the HIV epidemic.
A roll call from team Biden-Harris
POZ editors compile the winners, as voted on by readers, of the Fifth Annual POZ Awards, which spotlighted HIV/AIDS in media and culture.
Researchers from the Global HIV Pain Task Force seek input from the HIV/AIDS community.
HIV organizations and groups look forward to 2021 and closing in on the goal of ending HIV.
Good nutrition is key to overall health and can help you live long and well with HIV.
Who can safely receive COVID-19 vaccines?
Between 2010 and 2017, the HIV-related death rate fell by half.
People with untreated HIV in a recent study had signs of faster cell aging, which treatment reduced but did not eliminate.
A recent study sheds light on weight gain after switching to new form of tenofovir.
While people with HIV have a higher rate of early Alzheimer’s than those without the virus, treatment appears to eliminate this excess risk.
A study finds that long-acting cabotegravir is an effective PrEP option for women.
Switching to an integrase inhibitors is not tied to gain in bad fat, according to recent study.
Trials for HIV-positive people of a treatment using the CRISPR-Cas9 gene editing tool may be on the horizon.
Larger studies suggest people living with HIV might have a modestly higher risk of severe COVID-19, but much remains to be learned.
Shirlene Cooper empowers women living with HIV through art.
Read the digital edition!